Correlation Between CEIX Old and Opus Genetics,

Can any of the company-specific risk be diversified away by investing in both CEIX Old and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CEIX Old and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CEIX Old and Opus Genetics,, you can compare the effects of market volatilities on CEIX Old and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CEIX Old with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of CEIX Old and Opus Genetics,.

Diversification Opportunities for CEIX Old and Opus Genetics,

0.0

Correlation Coefficient

CEIX Old  Opus Genetics,

Pay attention - limited upside

The 3 months correlation between CEIX and Opus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CEIX Old and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and CEIX Old is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CEIX Old are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of CEIX Old i.e., CEIX Old and Opus Genetics, go up and down completely randomly.

Pair Corralation between CEIX Old and Opus Genetics,

If you would invest  83.00  in Opus Genetics, on December 18, 2024 and sell it today you would earn a total of  28.00  from holding Opus Genetics, or generate 33.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

CEIX Old  vs.  Opus Genetics,

CEIX Old

Risk-Adjusted Performance

Very Weak

Over the last 90 days CEIX Old has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, CEIX Old is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Opus Genetics,

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Opus Genetics, are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Opus Genetics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CEIX Old and Opus Genetics,

The main advantage of trading using opposite CEIX Old and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CEIX Old position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.

The idea behind CEIX Old and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.